Neoplasms, Plasma Cell
Showing 9951 - 9975 of >10,000
ALLoreactive T-Cell receptOr RePertoire in kidnEy
Recruiting
- Renal Transplant Rejection
- +3 more
- Mixed lymphocyte reaction
-
Vienna, AustriaMedical university of Vienna
Apr 5, 2022
Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)
Active, not recruiting
- Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- TG-1701
- +2 more
-
East Melbourne, Victoria, Australia
- +7 more
Jan 20, 2023
Post-polypectomy Bleeding, Colorectal Polyp Trial in Wuhan (argon plasma coagulation, clip closure)
Not yet recruiting
- Post-polypectomy Bleeding
- Colorectal Polyp
- argon plasma coagulation
- clip closure
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Feb 21, 2022
Breast Cancer, Healthy Volunteers Trial in Nottingham (amcenestrant, [14C]-SAR439859 microtracer, [14C]-SAR439859)
Completed
- Breast Cancer
- Healthy Volunteers
- amcenestrant
- +2 more
-
Nottingham, United KingdomInvestigational Site Number 8260001
Apr 21, 2022
Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
Not yet recruiting
- Delirium, Postoperative
- +2 more
- (no location specified)
Sep 18, 2023
Cytomegalovirus Infections Trial in Worldwide (maribavir, )
Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)
Recruiting
- Acute Leukemia
- mitoxantrone liposome
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 13, 2023
Tumors, Malignant Melanoma, Hematological Malignancies Trial in Chicago (Immunoablative Hematopoietic PBSC Transplant, Busulfan
Completed
- Tumors
- +4 more
- Immunoablative Hematopoietic PBSC Transplant
- +2 more
-
Chicago, IllinoisLurie Children's Hospital
Aug 28, 2019
Liver Transplantation, Erythrocyte Transfusion Trial in Rome (Red Blood Cell concentrates from organ donor)
Not yet recruiting
- Liver Transplantation
- Erythrocyte Transfusion
- Red Blood Cell concentrates from organ donor
-
Rome, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023
Peripheral T-cell Lymphomas (PTCL) Trial in Taiwan (Lenalidomide and Gemcitabine (Dose level 11), Lenalidomide and Gemcitabine
Not yet recruiting
- Peripheral T-cell Lymphomas (PTCL)
- Lenalidomide and Gemcitabine (Dose level 11)
- +3 more
-
Kaohsiung, Taiwan
- +3 more
Nov 1, 2021
Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)
Not yet recruiting
- Glioblastoma, IDH-wildtype
- +2 more
-
Milan, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Jun 26, 2023
Neat OGTT, OGTT With Added Sucralose, OGTT With Added Lactisole Trial in New Brunswick (TAS1R2/3 agonist or antagoinst admixture
Completed
- Neat OGTT
- +2 more
- TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test
-
New Brunswick, New JerseyRutgers, Department of Nutritional Sciences
Jun 2, 2023
Influenza Vaccination Trial in Singapore (Flublok Quadrivalent vaccine, Fluarix Quadrivalent vaccine, Flucelvax Quadrivalent
Not yet recruiting
- Influenza Vaccination
- Flublok Quadrivalent vaccine
- +2 more
-
Singapore, SingaporeNational Centre for Infectious Diseases (NCID)
Jul 26, 2022
Embolic Risk During Infective Endocarditis
Completed
- Infective Endocarditis
-
Besancon, France
- +1 more
Dec 20, 2021
Diabetic Foot Trial in Athens (Umbilical cord blood platelel lysate gel)
Recruiting
- Diabetic Foot
- Umbilical cord blood platelel lysate gel
-
Athens, Attiki, Greece
- +1 more
Jun 21, 2022
Suicide, Depression Trial in Montpellier (Blood samples, Hetero-questionnaires and auto-questionnaires, Magnetic Resonance
Not yet recruiting
- Suicide
- Depression
- Blood samples
- +2 more
-
Montpellier, FranceUniversity hospital
Sep 14, 2023
Metastatic Renal Cell Carcinoma Trial in Worldwide (Ipilimumab plus nivolumab, Standard Therapy)
Recruiting
- Metastatic Renal Cell Carcinoma
- Ipilimumab plus nivolumab
- Standard Therapy
-
Gent, Belgium
- +40 more
Feb 7, 2022
DLBCL, DLBCL Germinal Center B-Cell Type, DLBCL, Not Otherwise Specified Trial in Columbus (Molecular Nanotechnology)
Recruiting
- Diffuse Large B-Cell Lymphoma
- +3 more
- Molecular Nanotechnology
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 2, 2022
Parotid Tumors Trial in Hong Kong (Magnetic Resonance Imaging on 3T scanner (Magnetom Prisma, SIemens) with dedicated neurogram
Recruiting
- Parotid Neoplasms
- Magnetic Resonance Imaging on 3T scanner (Magnetom Prisma, SIemens) with dedicated neurogram sequences (Constructive interference in steady state - CISS; Dual Echo Steady State - DESS)
-
Hong Kong, Hong KongGerald Choa MRI Center
Mar 15, 2022
NSCLC, ALK Gene Rearrangement Positive Trial in France (RNAseq)
Recruiting
- Non-small Cell Lung Cancer
- ALK Gene Rearrangement Positive
- RNAseq
-
Saint-Denis, La RĂ©union, France
- +44 more
Nov 4, 2021
Breast Cancer Trial in Lutherville-Timonium (CS-1000 labeled SVF cells)
Withdrawn
- Breast Cancer
- CS-1000 labeled SVF cells
-
Lutherville-Timonium, MarylandCosmeticSurg
Jun 21, 2022
Langerhans Cell Histiocytosis Trial in Athens (Denosumab 70 MG/ML [Xgeva])
Completed
- Langerhans Cell Histiocytosis
- Denosumab 70 MG/ML [Xgeva]
-
Athens, Attiki, Greece251 Hellenic AirForce & VA General Hospital, Dpt of Endocrinolog
Oct 1, 2022
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
Pulmonary Arterial Hypertension Trial in Groningen (400 mg BIA 5-1058)
Completed
- Pulmonary Arterial Hypertension
- 400 mg BIA 5-1058
-
Groningen, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Jul 28, 2021